Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study

Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study

Abstract Background Evidence suggests that Greece is among the European countries with increased trend in HCV prevalence among injecting drug users (IDUs) from 2008 to 2014. Nonetheless, the access of IDUs to treatment for Hepatitis C Virus (HCV) is very limited while the risk of co-infection and tr...

Full description

Bibliographic Details
Main Authors: Kyriakos Souliotis, Eirini Agapidaki, Manto Papageorgiou, Niki Voudouri, Xenophon Contiades
Format: Article
Language:English
Published: BMC 2017-06-01
Series:International Journal for Equity in Health
Subjects:
Hepatitis C
HCV
Injecting drug users
Greece
Healthcare
Pharmaceuticals
Online Access:http://link.springer.com/article/10.1186/s12939-017-0601-3

Internet

http://link.springer.com/article/10.1186/s12939-017-0601-3

Similar Items